SeQuent Scientific Limited is a leading integrated pharmaceutical company based in India, specializing in animal health and human APIs (Active Pharmaceutical Ingredients). The company focuses on developing, manufacturing, and marketing products for the global market. SeQuent's primary goal is to improve the quality of life through innovative healthcare solutions.

SeQuent offers a wide range of high-quality animal health products such as feed additives, nutritional supplements, anti-infectives, parasiticides, and vaccines that cater to both livestock and companion animals.

In addition to its animal health segment, SeQuent also produces human APIs with a focus on niche therapeutic areas including oncology, hormones & steroids, controlled substances & semi-synthetic penicillins.

One factor that sets SeQuent apart from its competitors is its strong emphasis on research and development. The company has state-of-the-art R&D facilities equipped with advanced technologies that drive innovation in product development. This commitment to innovation enables SeQuent to introduce new products into the market consistently. Moreover, Sequent’s customer-centric approach ensures it provides tailored solutions addressing specific needs which further differentiates it from others in the industry. The company has garnered several partnerships and collaborations over the years. For instance,in 2021-22 they announced strategic partnership agreement with Immunostar Inc., USA . Such collaborations have enabled themto enhance their product offerings and expand their reach globally. Sequent Scientific continues evolving by adapting cutting-edge technology while maintaining an unwavering dedication towards improving global access to healthcare.